Benzodiazepine use, abuse, and dependenceO'BRIEN, Charles P.The Journal of clinical psychiatry. Supplement. 2005, Vol 66, Num 2, pp 28-33, 6 p.Conference Paper

Anticraving medications for relapse prevention : A possible new class of psychoactive medicationsO'BRIEN, Charles P.The American journal of psychiatry. 2005, Vol 162, Num 8, pp 1423-1431, issn 0002-953X, 9 p.Article

A 50-Year-Old Woman Addicted to Heroin : Review of Treatment of Heroin AddictionO'BRIEN, Charles P.JAMA, the journal of the American Medical Association. 2008, Vol 300, Num 3, pp 314-321, issn 0098-7484, 8 p.Article

Pharmacologic treatment of alcohol abuse and addictionO'BRIEN, Charles P.The Journal of clinical psychiatry. Supplement. 2001, Vol 62, Num 20, 48 p.Serial Issue

The use of selective serotonin reuptake inhibitors in treating alcoholic subtypesPETTINATI, Helen M.The Journal of clinical psychiatry. Supplement. 2001, Vol 62, Num 20, pp 26-31Article

Alcohol abuse and alcoholism : An overviewVOLPICELLI, Joseph R.The Journal of clinical psychiatry. Supplement. 2001, Vol 62, Num 20, pp 4-10Article

Treatment of alcohol-dependent outpatients with acamprosate : A clinical reviewMASON, Barbara J.The Journal of clinical psychiatry. Supplement. 2001, Vol 62, Num 20, pp 42-48Article

Neuroplasticity in addictive disordersO'BRIEN, Charles P.Dialogues in clinical neuroscience. 2009, Vol 11, Num 3, pp 350-353, issn 1294-8322, 4 p.Article

Cocaine dependence: a disease of the brain's reward centersDACKIS, Charles A; O'BRIEN, Charles P.Journal of substance abuse treatment. 2001, Vol 21, Num 3, pp 111-117, issn 0740-5472Article

Pharmacologic approaches to the management of alcoholismANTON, Raymond F.The Journal of clinical psychiatry. Supplement. 2001, Vol 62, Num 20, pp 11-17Article

Current Status of Co-Occurring Mood and Substance Use Disorders: A New Therapeutic TargetPETTINATI, Helen M; O'BRIEN, Charles P; DUNDON, William D et al.The American journal of psychiatry. 2013, Vol 170, Num 1, pp 23-30, issn 0002-953X, 8 p.Article

Pharmacogenetic approaches to the treatment of alcohol addiction : Addiction: from mechanism to treatmentHEILIG, Markus; GOLDMAN, David; BERRETTINI, Wade et al.Nature reviews. Neuroscience (Print). 2011, Vol 12, Num 11, pp 670-684, issn 1471-003X, 15 p.Article

The role of selective serotonin reuptake inhibitors in reducing alcohol consumptionNARANJO, Claudio A; KNOKE, Della M.The Journal of clinical psychiatry. Supplement. 2001, Vol 62, Num 20, pp 18-25Article

Acute baclofen diminishes resting baseline blood flow to limbic structures: A perfusion fMRI studyFRANKLIN, Teresa R; SHIN, Joshua; JAGANNATHAN, Kanchana et al.Drug and alcohol dependence. 2012, Vol 125, Num 1-2, pp 60-66, issn 0376-8716, 7 p.Article

Effects of Varenicline on Smoking Cue-Triggered Neural and Craving ResponsesFRANKLIN, Teresa; ZE WANG; SUH, Jesse J et al.Archives of general psychiatry. 2011, Vol 68, Num 5, pp 516-526, issn 0003-990X, 11 p.Article

Modulation of resting brain cerebral blood flow by the GABA B agonist, baclofen: A longitudinal perfusion fMRI studyFRANKLIN, Teresa R; ZE WANG; O'BRIEN, Charles P et al.Drug and alcohol dependence. 2011, Vol 117, Num 2-3, pp 176-183, issn 0376-8716, 8 p.Article

A Double-Blind, Placebo-Controlled Trial Combining Sertraline and Naltrexone for Treating Co-Occurring Depression and Alcohol DependencePETTINATI, Helen M; OSLIN, David W; KAMPMAN, Kyle M et al.The American journal of psychiatry. 2010, Vol 167, Num 6, pp 668-675, issn 0002-953X, 8 p.Article

Genetic variants in the cocaine-and amphetamine-regulated transcript gene (CARTPT) and cocaine dependenceLOHOFF, Falk W; BLOCH, Paul J; OSLIN, David W et al.Neuroscience letters. 2008, Vol 440, Num 3, pp 280-283, issn 0304-3940, 4 p.Article

Hepatic Safety of Once-Monthly Injectable Extended-Release Naltrexone Administered to Actively Drinking AlcoholicsLUCEY, Michael R; SILVERMAN, Bernard L; ILLEPERUMA, Ari et al.Alcoholism, clinical and experimental research. 2008, Vol 32, Num 3, pp 498-504, issn 0145-6008, 7 p.Article

Concurrent cocaine withdrawal alters alcohol withdrawal symptomsKAMPMAN, Kyle M; PETTINATI, Helen; VOLPICELLI, Joseph et al.Journal of addictive diseases. 2002, Vol 21, Num 4, pp 13-26, issn 1055-0887, 14 p.Article

Effect of naltrexone on oral consumption of concurrently available ethanol and cocaine in the ratSTROMBERG, Michael F; SENGPIEL, Till; MACKLER, Scott A et al.Alcohol (Fayetteville, NY). 2002, Vol 28, Num 3, pp 169-179, issn 0741-8329, 11 p.Article

Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluationMCLELLAN, A. Thomas; LEWIS, David C; O'BRIEN, Charles P et al.JAMA, the journal of the American Medical Association. 2000, Vol 284, Num 13, pp 1689-1695, issn 0098-7484Article

Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependenceLANGLEBEN, Daniel D; BUSCH, Elliot L; O'BRIEN, Charles P et al.Psychopharmacologia. 2012, Vol 220, Num 3, pp 559-564, issn 0033-3158, 6 p.Article

Drug Treatment as HIV Prevention: A Research UpdateMETZGER, David S; WOODY, George E; O'BRIEN, Charles P et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 55, issn 1525-4135, S32-S36, SUP1Article

DAT Genotype Modulates Brain and Behavioral Responses Elicited by Cigarette CuesFRANKLIN, Teresa R; LOHOFF, Falk W; BERRETTINI, Wade et al.Neuropsychopharmacology (New York, NY). 2009, Vol 34, Num 3, pp 717-728, issn 0893-133X, 12 p.Article